CIBRA Capital Ltd Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0002060725
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 18 positions · Total reported value $58.24M · Top-10 concentration 77.8% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 86.5% · 19 new · 1 cut · 12 exited
Active Share (vs S&P 500): 99.9% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2025 13F filing, CIBRA Capital Ltd disclosed 18 equity positions with a combined reported value of $58.24M. The filing implies a focused portfolio: its ten largest positions account for 77.8% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q4 2025 were CFLT ($5.49M), NSC ($5.07M), CYBR ($5.04M). By sector, the heaviest allocations are Industrials 8.7%, Consumer Discretionary 3.7%. Versus the prior quarter, allocation shifted toward Industrials (+8.7pp), Financials (+3.4pp) and away from Other (-15.7pp).
Versus the prior quarter, CIBRA Capital Ltd opened 19 new positions, trimmed 1 and fully exited 12, a turnover rate of 86.5% of positions. The portfolio's overlap with the prior quarter was 0% of names.
The largest new positions opened in Q4 2025 were CFLT ($5.49M), NSC ($5.07M), CYBR ($5.04M).
Of the 12 positions fully exited versus the prior quarter, the largest were ITCI ($54.91M), K ($37.09M), BERY ($29.65M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
Fully Exited (vs previous quarter)
- ITCI INTRA-CELLULAR THERAPIES INC · prev qtr: $54.91M
- K KELLANOVA · prev qtr: $37.09M
- BERY BERRY GLOBAL GROUP INC · prev qtr: $29.65M
- HES HESS CORP · prev qtr: $27.74M
- DESP DESPEGAR COM CORP · prev qtr: $25.18M
- FYBR FRONTIER COMMUNICATIONS PARE · prev qtr: $20.98M
- AMED AMEDISYS INC · prev qtr: $20.08M
- FNA PARAGON 28 INC · prev qtr: $12.17M
Insider Transactions (Form 4)
Latest CIBRA Capital Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
CIBRA Capital Ltd files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q1 2026) lists 25 positions worth $207.21M in total. HoldingsHub carries 4 quarters of its filings (Q4 2024–Q1 2026).
Firm Snapshot
- SEC registration: 801-135347 (status: Approved), registered 2026-02-17
- Regulatory AUM (Form ADV): $263.00M as of 2026-06-12
- Client mix (by RAUM): pension and profit-sharing plans 100%
Portfolio Structure
- 25 positions · $207.21M reported value (Q1 2026)
- Top 10 holdings = 73.1% of reported value
- Largest position: FOLD (AMICUS THERAPEUTICS INC) at 11.8%
- Average position size: $8.29M
Sector Tilt
- Utilities 8.0%
- Materials 7.6%
- Health Care 5.0%
- (classified holdings cover 36% of value)
Quarterly Activity
- Q1 2026: 19 new, 5 added, 1 reduced, 12 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
181.50K | $5.49M | 9.42% | New | |
| 2 |
|
17.55K | $5.07M | 8.70% | New | |
| 3 |
|
11.29K | $5.04M | 8.65% | New | |
| 4 |
|
24.51K | $5.01M | 8.60% | New | |
| 5 |
|
22.99K | $4.74M | 8.14% | New | |
| 6 |
|
62.84K | $4.68M | 8.04% | New | |
| 7 |
|
18.71K | $4.13M | 7.10% | New | |
| 8 |
|
39.40K | $4.00M | 6.87% | New | |
| 9 |
|
53.21K | $3.84M | 6.59% | New | |
| 10 |
|
74.97K | $3.34M | 5.74% | New | |
| 11 |
|
210.80K | $3.00M | 5.15% | New | |
| 12 |
|
124.00K | $2.14M | 3.67% | New | |
| 13 |
|
130.80K | $2.01M | 3.44% | New | |
| 14 |
|
256.00K | $1.59M | 2.73% | New | |
| 15 |
|
37.84K | $1.09M | 1.87% | New | |
| 16 |
|
6.43K | $1.09M | 1.87% | New | |
| 17 |
|
21.00K | $998.97K | 1.72% | New | |
| 18 |
|
76.00K | $988.76K | 1.70% | New | |
FAQ
What did CIBRA Capital Ltd buy in 2025-Q4?
In its 2025-Q4 13F filing, CIBRA Capital Ltd reported 18 equity positions worth $58.24M in aggregate; its largest disclosed positions were CFLT ($5.49M), NSC ($5.07M), CYBR ($5.04M).
How large is CIBRA Capital Ltd's portfolio?
CIBRA Capital Ltd reported $58.24M of long equity holdings across 18 positions as of 2025-Q4. Top-10 holdings account for 77.8% of reported value.
What is CIBRA Capital Ltd's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.